Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' Fielding, RM' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 12 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Fielding, RM
      Relationship of pharmacokinetically-calculated volumes of distribution to the physiologic distribution of liposomal drugs in tissues: Implications for the characterization of liposomal formulations

      PHARMACEUTICAL RESEARCH
    2. Bekersky, I; Fielding, RM; Dressler, DE; Kline, S; Buell, DN; Walsh, TJ
      Pharmacokinetics, excretion, and mass balance of C-14 after administrationof C-14-cholesterol-labeled AmBisome to healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    3. Bekersky, I; Boswell, GW; Hiles, R; Fielding, RM; Buell, D; Walsh, TJ
      Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphotericin B (AmBisome (R)): A 91-day study in rats

      PHARMACEUTICAL RESEARCH
    4. Bekersky, I; Fielding, RM; Buell, D; Lawrence, I
      Lipid-based amphotericin B formulations: from animals to man

      PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY
    5. Fielding, RM; Lasic, DD
      Liposomes in the treatment of infectious diseases

      EXPERT OPINION ON THERAPEUTIC PATENTS
    6. Fielding, RM; Moon-McDermott, L; Lewis, RO
      Bioavailability of a small unilamellar low-clearance liposomal amikacin formulation after extravascular administration

      JOURNAL OF DRUG TARGETING
    7. Bekersky, I; Boswell, GW; Hiles, R; Fielding, RM; Buell, D; Walsh, TJ
      Safety and toxicokinetics of intravenous liposomal amphotericin B (AmBisome (R)) in beagle dogs

      PHARMACEUTICAL RESEARCH
    8. Fielding, RM; Moon-Mcdermott, L; Lewis, RO; Horner, MJ
      Pharmacokinetics and urinary excretion of amikacin in low-clearance unilamellar liposomes after a single or repeated intravenous administration in the rhesus monkey

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    9. FIELDING RM; LEWIS RO; MOONMCDERMOTT L
      ALTERED TISSUE DISTRIBUTION AND ELIMINATION OF AMIKACIN ENCAPSULATED IN UNILAMELLAR, LOW-CLEARANCE LIPOSOMES (MIKASOME(R))

      Pharmaceutical research
    10. WANG LH; FIELDING RM; SMITH PC; GUO LSS
      COMPARATIVE TISSUE DISTRIBUTION AND ELIMINATION OF AMPHOTERICIN-B COLLOIDAL DISPERSION (AMPHOCIL(R)) AND FUNGIZONES(R) AFTER REPEATED DOSING IN RATS

      Pharmaceutical research
    11. RIOUX F; PETITCLERC E; AUDET R; DRAPEAU G; FIELDING RM; MARCEAU F
      RECOMBINANT HUMAN HEMOGLOBIN INHIBITS BOTH CONSTITUTIVE AND CYTOKINE-INDUCED NITRIC OXIDE-MEDIATED RELAXATION OF RABBIT ISOLATED AORTIC RINGS

      Journal of cardiovascular pharmacology
    12. SPAHN DR; FIELDING RM; GILLESPIE R; HOFFMAN RD; SMITH LR; ARCHERPAIK LE; LEONE BJ
      CARDIOVASCULAR EFFECTS OF RECOMBINANT HUMAN HEMOGLOBIN (RHB1.1) IN A CANINE MODEL OF NORMOVOLEMIC HEMODILUTION

      British Journal of Anaesthesia


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 13/08/20 alle ore 02:25:34